Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
2,363,225
-
Share change
-
+51,956
-
Total reported value
-
$6,735,000
-
Price per share
-
$2.85
-
Number of holders
-
12
-
Value change
-
+$148,414
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) as of Q2 2019
As of 30 Jun 2019,
ONCONOVA THERAPEUTICS INC - COM PAR (ONTX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,363,225 shares.
The largest 10 holders included
683 Capital Management, LLC, TYNDALL CAPITAL PARTNERS L P, Point72 Asset Management, L.P., Kepos Capital LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.